Androgens in Patients With Luminal B and HER2 Breast Cancer Might Be a Biomarker Promoting Anti-PD-1 Efficacy

por Li, Peng, Yuan, Wenhui, Wu, Ruan, Zeng, Chuqian, Li, Ke, Lu, Ligong
Publicado 2022

Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell

por Zhu, Xinhai, Li, Ke, Liu, Guichao, Wu, Ruan, Zhang, Yan, Wang, Siying, Xu, Meng, Lu, Ligong, Li, Peng
Publicado 2023

1α,25(OH)(2)D(3) ameliorates insulin resistance by alleviating γδ T cell inflammation via enhancing fructose-1,6-bisphosphatase 1 expression

por Li, Peng, Li, Ke, Yuan, Wenhui, Xu, Yuqi, Li, Ping, Wu, Ruan, Han, Jingru, Yin, Zhinan, Lu, Ligong, Gao, Yunfei
Publicado 2023

IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer

por Li, Peng, Wu, Ruan, Li, Ke, Yuan, Wenhui, Zeng, Chuqian, Zhang, Yuting, Wang, Xiao, Zhu, Xinhai, Zhou, Jianjun, Li, Ping, Gao, Yunfei
Publicado 2021

1α,25(OH)(2)D(3) reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells

por Li, Peng, Zhu, Xinhai, Cao, Guangchao, Wu, Ruan, Li, Ke, Yuan, Wenhui, Chen, Biyun, Sun, Guodong, Xia, Xichun, Zhang, Hua, Wang, Xiao, Yin, Zhinan, Lu, Ligong, Gao, Yunfei
Publicado 2022